65719 Hofheim am Taunus, de
+49 (6192) 470113-51
Cyntegrity Launches MyRBQM® Portal, The First One-Stop Clinical Trial Optimization Solution
“We are pleased to give clinical organizations the ability to make risk-based strategies really work while staying on budget. For those who want to explore its powerful features we provide a free user license that grants access to services such as our unique indication focused RACTs, self-learning risk mitigation actions libraries, and Central Statistical Monitoring module. Our new portal opens the door to fully fledged risk-based quality management. It’s another step in our master plan to fuel the clinical research community. Unlike the few generic business analytics tools out there, we’ve designed MyRBQM® Portal to be compliant, applicable and complete by design. It’s the first turnkey product that integrates regulatory guidance, connects and aggregates all clinical data sources, automates risk communication, and applies specific analytical and statistical methods. We’ve created a complete collaboration experience, bringing all clinical risks into scope from start to finish. The novel concept behind MyRBQM® Portal makes de-risking clinical trials affordable to all.”, says Dr Artem Andrianov, CEO of Cyntegrity.
MyRBQM® Portal – Your Gateway to Clinical Success
Cyntegrity is the first to provide the industry with indication focused risk assessment tools, such as the customizable Oncology, Diabetes and Medical Devices RACTs. In addition, MyRBQM® Portal holds a comprehensive KRI engine with over 250 categorized and validated key risk indicators, enhanced with complementary risk mitigation actions libraries.
“Once clinical monitors and others involved in a clinical study start working with MyRBQM® Portal they will understand the true value of this service. The built-in intelligence and self-learning aspects of the portal will help them combat risks at source and save time and effort when setting up the next study”, explains Cyntegrity’s Chief Scientific Officer, Dr Johann Proeve.
The use of information published here for personal information and editorial processing is generally free of charge. Please clarify any copyright issues with the stated publisher before further use. In the event of publication, please send a specimen copy to firstname.lastname@example.org.